Cargando…
Therapeutic effects of clonazepam in patients with burning mouth syndrome and various symptoms or psychological conditions
Burning mouth syndrome (BMS) is frequently accompanied by dysgeusia and xerostomia. Clonazepam has been widely prescribed and is effective, but it is unclear whether clonazepam also affects the symptoms that accompany BMS, or whether such symptoms affect treatment outcomes. Here, we investigated the...
Autores principales: | Shin, Hyun-Il, Bang, Joo-In, Kim, Geun-Jeon, Kim, Mi Ra, Sun, Dong-Il, Kim, Sang-Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160112/ https://www.ncbi.nlm.nih.gov/pubmed/37142613 http://dx.doi.org/10.1038/s41598-023-33983-6 |
Ejemplares similares
-
Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome
por: Zborowski, Jacek, et al.
Publicado: (2022) -
Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome
por: Castillo-Felipe, Candela, et al.
Publicado: (2022) -
Careful use of clonazepam and alpha lipoid acid in burning mouth syndrome treatment
por: Suga, Takayuki, et al.
Publicado: (2021) -
Clonazepam Treatment of Pathologic Childhood Aerophagia with Psychological Stresses
por: Hwang, Jin-Bok, et al.
Publicado: (2007) -
Perineural Invasion Predicts Local Recurrence and Poor Survival in Laryngeal Cancer
por: Shin, Hyun-Il, et al.
Publicado: (2023)